GREY:ICOTF - Post by User
Post by
DrHolidayon Jun 24, 2018 4:05pm
100 Views
Post# 28221061
The elusive butterfly of love
The elusive butterfly of love"Oh, Hoto is going dancing to LaLaland to pick daisies and buttercups and chase elusive PDP butterflies now that he is out of ICO, and then to sow doubt here while pumping up his new play".
It would appear that he himself has forgotten the bullish investment case for ICO, or is he a scalper in reality merely trying to bash ICO lower for a repurchase? If you follow the money, you will realize that the big players did indeed take a profit, but understand the size of the market and how Oral B Amphotericin could be a game changer and challenge Gilead's billion dollar market share for the injectable version which has been around for 50 years. If you think that AstraZeneca has no interest in Oral B, then you are sadly mistaken. I don't know when the US32 million dollar milestone payment option must be paid. It might not be until successful Phase 3 trials. Meanwhile, ICO could easily do a small financing at a premium to the market and close it in a done deal in a heartbeat just to tide them over to continue work and proceed to Phase 2.
Mark my words that AstraZeneca will be watching ICO for phase 1 trial results in July, and taking
an eqity stake in ICO would be a strategic move, and help to defend against any hostility by unfriendly competitors who do not want to lose market share to Oral B Amphotericin.
https://www.youtube.com/watch?v=2JyMGb-d8Io